报销
病入膏肓
临终关怀
医学
护理部
认证
盐湖
疗养院
家庭医学
医疗保健
业务
缓和医疗
古生物学
经济
法学
构造盆地
生物
经济增长
政治学
出处
期刊:American Journal of Health-system Pharmacy
[Oxford University Press]
日期:1984-05-01
卷期号:41 (5): 942-944
被引量:1
标识
DOI:10.1093/ajhp/41.5.942
摘要
Recently enacted regulations regarding Medicare coverage of hospice care are discussed. The hospice benefit, whether provided in a home or inpatient setting, is available to individuals entitled to Medicare Part A benefits and who are certified as being terminally ill. Hospice care coverage is authorized for a maximum of six months plus 30 days. Conditions of participation of the final regulations require that critical services (nursing services, physician services, and drugs and biologicals) be available on a 24-hour basis. Also, freestanding hospices must employ or contract a licensed pharmacist for control and accountability of all drugs throughout the facility. Reimbursement rates are mandated as all-inclusive, per diem rates that favor home care and have a per capita limit of $6500. The hospice benefit is a distinctly new choice of care for terminally ill patients. It also provides pharmacists an opportunity to participate in a unique aspect of health care.
科研通智能强力驱动
Strongly Powered by AbleSci AI